Cargando…
Serum LDH level may predict outcome of chronic lymphocytic leukemia patients with a 17p deletion: a retrospective analysis of prognostic factors in China
OBJECTIVE: This study aims to evaluate the natural history of patients with chronic lymphocytic leukemia (CLL) and a 17p deletion (17p-) and identify the predictive factors within this subgroup. METHODS: The sample of patients with CLL were analyzed by fluorescencein situ hybridization for deletions...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422418/ https://www.ncbi.nlm.nih.gov/pubmed/28536495 http://dx.doi.org/10.21147/j.issn.1000-9604.2017.02.09 |
_version_ | 1783234771201032192 |
---|---|
author | Li, Heng Xiong, Wenjie Liu, Huimin Yi, Shuhua Yu, Zhen Liu, Wei Lyu, Rui Wang, Tingyu Zou, Dehui Li, Zengjun Qiu, Lugui |
author_facet | Li, Heng Xiong, Wenjie Liu, Huimin Yi, Shuhua Yu, Zhen Liu, Wei Lyu, Rui Wang, Tingyu Zou, Dehui Li, Zengjun Qiu, Lugui |
author_sort | Li, Heng |
collection | PubMed |
description | OBJECTIVE: This study aims to evaluate the natural history of patients with chronic lymphocytic leukemia (CLL) and a 17p deletion (17p-) and identify the predictive factors within this subgroup. METHODS: The sample of patients with CLL were analyzed by fluorescencein situ hybridization for deletions in chromosome bands 11q22, 13q14 and 17p13; trisomy of bands 12q13; and translocation involving band 14q32. The data from 456 patients with or without a 17p- were retrospectively collected and analyzed. RESULTS: The overall response rate (ORR) in patients with a 17p- was 56.9%, and patients with a high percentage of 17p- (defined as more than 25% of cells harbouring a 17p-) had a lower ORR. The median overall survival (OS) in patients with a 17p- was 78.0 months, which was significantly shorter than the OS in patients without this genetic abnormality (median 162.0 months, P<0.001). Within the subgroup with a 17p-, the progression-free survival was significantly shorter in patients at Binet stage B-C and patients with elevated lactate dehydrogenase (LDH), B symptoms, unmutatedIGHV and a high percentage of 17p-. CONCLUSIONS: These results indicated that patients with a 17p- CLL have a variable prognosis that might be predicted using simple clinical and laboratory characteristics. |
format | Online Article Text |
id | pubmed-5422418 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-54224182017-05-23 Serum LDH level may predict outcome of chronic lymphocytic leukemia patients with a 17p deletion: a retrospective analysis of prognostic factors in China Li, Heng Xiong, Wenjie Liu, Huimin Yi, Shuhua Yu, Zhen Liu, Wei Lyu, Rui Wang, Tingyu Zou, Dehui Li, Zengjun Qiu, Lugui Chin J Cancer Res Original Article OBJECTIVE: This study aims to evaluate the natural history of patients with chronic lymphocytic leukemia (CLL) and a 17p deletion (17p-) and identify the predictive factors within this subgroup. METHODS: The sample of patients with CLL were analyzed by fluorescencein situ hybridization for deletions in chromosome bands 11q22, 13q14 and 17p13; trisomy of bands 12q13; and translocation involving band 14q32. The data from 456 patients with or without a 17p- were retrospectively collected and analyzed. RESULTS: The overall response rate (ORR) in patients with a 17p- was 56.9%, and patients with a high percentage of 17p- (defined as more than 25% of cells harbouring a 17p-) had a lower ORR. The median overall survival (OS) in patients with a 17p- was 78.0 months, which was significantly shorter than the OS in patients without this genetic abnormality (median 162.0 months, P<0.001). Within the subgroup with a 17p-, the progression-free survival was significantly shorter in patients at Binet stage B-C and patients with elevated lactate dehydrogenase (LDH), B symptoms, unmutatedIGHV and a high percentage of 17p-. CONCLUSIONS: These results indicated that patients with a 17p- CLL have a variable prognosis that might be predicted using simple clinical and laboratory characteristics. AME Publishing Company 2017-04 /pmc/articles/PMC5422418/ /pubmed/28536495 http://dx.doi.org/10.21147/j.issn.1000-9604.2017.02.09 Text en Copyright © 2017 Chinese Journal of Cancer Research. All rights reserved. http://creativecommons.org/licenses/by-nc-sa/4.0/ This work is licensed under a Creative Commons Attribution-Non Commercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ |
spellingShingle | Original Article Li, Heng Xiong, Wenjie Liu, Huimin Yi, Shuhua Yu, Zhen Liu, Wei Lyu, Rui Wang, Tingyu Zou, Dehui Li, Zengjun Qiu, Lugui Serum LDH level may predict outcome of chronic lymphocytic leukemia patients with a 17p deletion: a retrospective analysis of prognostic factors in China |
title | Serum LDH level may predict outcome of chronic lymphocytic leukemia patients with a 17p deletion: a retrospective analysis of prognostic factors in China |
title_full | Serum LDH level may predict outcome of chronic lymphocytic leukemia patients with a 17p deletion: a retrospective analysis of prognostic factors in China |
title_fullStr | Serum LDH level may predict outcome of chronic lymphocytic leukemia patients with a 17p deletion: a retrospective analysis of prognostic factors in China |
title_full_unstemmed | Serum LDH level may predict outcome of chronic lymphocytic leukemia patients with a 17p deletion: a retrospective analysis of prognostic factors in China |
title_short | Serum LDH level may predict outcome of chronic lymphocytic leukemia patients with a 17p deletion: a retrospective analysis of prognostic factors in China |
title_sort | serum ldh level may predict outcome of chronic lymphocytic leukemia patients with a 17p deletion: a retrospective analysis of prognostic factors in china |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422418/ https://www.ncbi.nlm.nih.gov/pubmed/28536495 http://dx.doi.org/10.21147/j.issn.1000-9604.2017.02.09 |
work_keys_str_mv | AT liheng serumldhlevelmaypredictoutcomeofchroniclymphocyticleukemiapatientswitha17pdeletionaretrospectiveanalysisofprognosticfactorsinchina AT xiongwenjie serumldhlevelmaypredictoutcomeofchroniclymphocyticleukemiapatientswitha17pdeletionaretrospectiveanalysisofprognosticfactorsinchina AT liuhuimin serumldhlevelmaypredictoutcomeofchroniclymphocyticleukemiapatientswitha17pdeletionaretrospectiveanalysisofprognosticfactorsinchina AT yishuhua serumldhlevelmaypredictoutcomeofchroniclymphocyticleukemiapatientswitha17pdeletionaretrospectiveanalysisofprognosticfactorsinchina AT yuzhen serumldhlevelmaypredictoutcomeofchroniclymphocyticleukemiapatientswitha17pdeletionaretrospectiveanalysisofprognosticfactorsinchina AT liuwei serumldhlevelmaypredictoutcomeofchroniclymphocyticleukemiapatientswitha17pdeletionaretrospectiveanalysisofprognosticfactorsinchina AT lyurui serumldhlevelmaypredictoutcomeofchroniclymphocyticleukemiapatientswitha17pdeletionaretrospectiveanalysisofprognosticfactorsinchina AT wangtingyu serumldhlevelmaypredictoutcomeofchroniclymphocyticleukemiapatientswitha17pdeletionaretrospectiveanalysisofprognosticfactorsinchina AT zoudehui serumldhlevelmaypredictoutcomeofchroniclymphocyticleukemiapatientswitha17pdeletionaretrospectiveanalysisofprognosticfactorsinchina AT lizengjun serumldhlevelmaypredictoutcomeofchroniclymphocyticleukemiapatientswitha17pdeletionaretrospectiveanalysisofprognosticfactorsinchina AT qiulugui serumldhlevelmaypredictoutcomeofchroniclymphocyticleukemiapatientswitha17pdeletionaretrospectiveanalysisofprognosticfactorsinchina |